Loading provider…
Loading provider…
Infectious Disease Physician in Winston Salem, NC
NPI: 1538145800Primary Practice Location
NOVANT HEALTH FORSYTH MEDICAL CENTER
6915 Village Medical Cir, Clemmons, NC
Primary Employer
NH Forsyth Specialty Clinics
novanthealth.org
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
NC State Medical License
1999 - 2026
VA State Medical License
2004 - 2006
TN State Medical License
2002 - 2005

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Infectious Disease
University of Florida
MPH • Public Health Practice
2014 - 2017
Vanderbilt University Medical Center
vumc.org
Fellowship • Infectious Disease
2002 - 2004
Wake Forest University Baptist Medical Center
Residency • Internal Medicine
1999 - 2002
Wake Forest University
Biology
1991 - 1995
Wake Forest School of Medicine
school.wakehealth.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 29 | 48 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 18 | 26 |
Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach.
Authors: Michael Morgan, Timothy Darnell, Adwait Silwal, Stephen Weber
Publication Date: 2016-08-30
Authors: Priest, David H, Peacock, James E
Journal: South Med J
Authors: DeCamillis, Rebekah B, Hekman, Aliza L, Priest, David H
Journal: Clin Liver Dis (Hoboken)
Publication Date: 2024-01-25
Lead Sponsor: Ansun Biopharma, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: DAS181 OL, DRUG: DAS181, DRUG: DAS181 COVID-19